Vista Current Coverage

A Breast Cancer Highlight: “Study Finds Mammography Usage Has Increased When ACA Copayments Ended”

View Disclaimer

Recently, The Journal of Clinical Pathways published an interesting story regarding the results of a study regarding the cost-sharing or copayments regarding mammography in breast cancer that had been formally published in The New England Journal of Medicine (January 2018;378:262-269).

Amal N Trivedi, MD, MPH, associate professor of health services, Brown University, and colleagues conducted a difference-in-differences study of biennial screening mammography among 15,085 patients aged 65 to 74 years in 24 Medicare Advantage plans that eliminated cost-sharing to provide full coverage of screening mammography. The data were compared to that of 52,035 patients in 48 matched control plans that had maintained full coverage. The rate of mammogram use increased by nearly 6% among older patients who were recommended for screening after the Affordable Care Act (ACA) eliminated co-payments.

Vista Partners recently (01-22-18) published a Report on Seattle based Atossa Genetics Inc. (NASDAQ: ATOS), a clinical-stage drug company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. They believe their innovative therapies and delivery methods can transform breast cancer treatment.
DOWNLOAD the FREE Report at http://www.vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/.

Mammogram Use Increases After ACA Cost-Sharing Eliminated

The rate of mammogram use increased by nearly 6% among older patients who were recommended for screening after the Affordable Care Act eliminated co-payments…

www.journalofclinicalpathways.com

Read Full Article